Jane Street’s BioTelemetry, Inc. BEAT Stock Holding History

Jane Street’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-131,600	Closed	-$9.49M	–	10015
2020 Q4	$9.49M	Buy	131,600 +75,400	+134%	+$3.95M	﹤0.01%	1457
2020 Q3	$2.56M	Buy	56,200 +37,900	+207%	+$1.58M	﹤0.01%	2664
2020 Q2	$827K	Buy	+18,300	New	+$820K	﹤0.01%	4344
2019 Q2	–	Sell	-24,100	Closed	-$1.51M	–	6153
2019 Q1	$1.51M	Buy	+24,100	New	+$1.66M	﹤0.01%	2331

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Jane Street's BEAT Position: Q1 2021 in Review

Jane Street sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 28,429 shares — an estimated $2.05M sold.

Jane Street first reported a position in BEAT in Q2 2013 and held it in 11 quarters. The position peaked at $2.05M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Jane Street reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Jane Street sold 28,429 BioTelemetry, Inc. shares in Q1 2021, an estimated $2.05M.
Jane Street first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 11 quarters.
Jane Street's BioTelemetry, Inc. position peaked at $2.05M in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Jane Street's 13F filing for Q1 2021, filed 18 May 2021.